MX2010010016A - Preparacion de composicion farmaceutica para aumentar densidad mineral osea. - Google Patents
Preparacion de composicion farmaceutica para aumentar densidad mineral osea.Info
- Publication number
- MX2010010016A MX2010010016A MX2010010016A MX2010010016A MX2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A MX 2010010016 A MX2010010016 A MX 2010010016A
- Authority
- MX
- Mexico
- Prior art keywords
- cart
- preparation
- pharmaceutical composition
- derived peptide
- bone mineral
- Prior art date
Links
- 210000000988 bone and bone Anatomy 0.000 title abstract 2
- 229910052500 inorganic mineral Inorganic materials 0.000 title abstract 2
- 239000011707 mineral Substances 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 102100035932 Cocaine- and amphetamine-regulated transcript protein Human genes 0.000 abstract 5
- 101000715592 Homo sapiens Cocaine- and amphetamine-regulated transcript protein Proteins 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 4
- 210000002966 serum Anatomy 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
- A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La presente invención se refiere al uso de una cocaína y un péptido derivado de la transcripción regulada por anfetamina (CART) para la preparación de una composición farmacéutica para el aumento de la densidad mineral ósea proporcionando continuamente niveles elevados en suero del péptido derivado de CART en un sujeto que será tratado. Convenientemente, los niveles elevados en suero del péptido derivado de CART se proporcionan continuamente a través de la liberación lenta del péptido derivado de CART durante un periodo de tiempo prolongado de una formulación dé liberación lenta.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08005279 | 2008-03-20 | ||
| PCT/EP2009/053149 WO2009115525A2 (en) | 2008-03-20 | 2009-03-17 | Preparation of a pharmaceutical composition for increasing bone mineral density |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2010010016A true MX2010010016A (es) | 2010-09-30 |
Family
ID=39744830
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2010010016A MX2010010016A (es) | 2008-03-20 | 2009-03-17 | Preparacion de composicion farmaceutica para aumentar densidad mineral osea. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20100075893A1 (es) |
| EP (1) | EP2265280A2 (es) |
| JP (1) | JP2011515363A (es) |
| KR (1) | KR20100135751A (es) |
| CN (1) | CN101977624A (es) |
| AR (1) | AR071010A1 (es) |
| AU (1) | AU2009226966A1 (es) |
| BR (1) | BRPI0908423A2 (es) |
| CA (1) | CA2717459A1 (es) |
| CL (1) | CL2009000675A1 (es) |
| CO (1) | CO6290697A2 (es) |
| IL (1) | IL207542A0 (es) |
| MX (1) | MX2010010016A (es) |
| PE (1) | PE20091690A1 (es) |
| RU (1) | RU2010142903A (es) |
| TW (1) | TW201000117A (es) |
| WO (1) | WO2009115525A2 (es) |
| ZA (1) | ZA201006004B (es) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103030689B (zh) * | 2012-12-27 | 2014-09-24 | 无锡米度生物技术有限公司 | 一种cart多肽化合物及其制备方法和应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9522403D0 (en) * | 1995-11-01 | 1996-01-03 | Hoechst Roussel Ltd | Intravaginal drug delivery device |
| JP2002538757A (ja) * | 1997-03-26 | 2002-11-12 | ノボ ノルディスク アクティーゼルスカブ | 食欲制御活性を有するポリペプチド |
| US20070203058A1 (en) * | 2003-09-19 | 2007-08-30 | Novo Nordisk A/S | Novel Glp-1 Derivatives |
| ITMI20061545A1 (it) * | 2006-08-02 | 2008-02-03 | Mediolanum Pharmaceuticals Ltd | Particelle in grado di rilasciare il principio attivo per un periodo prolungato di tempo |
-
2009
- 2009-03-17 WO PCT/EP2009/053149 patent/WO2009115525A2/en not_active Ceased
- 2009-03-17 BR BRPI0908423-1A patent/BRPI0908423A2/pt not_active IP Right Cessation
- 2009-03-17 MX MX2010010016A patent/MX2010010016A/es not_active Application Discontinuation
- 2009-03-17 RU RU2010142903/15A patent/RU2010142903A/ru unknown
- 2009-03-17 EP EP09721933A patent/EP2265280A2/en not_active Withdrawn
- 2009-03-17 KR KR1020107020784A patent/KR20100135751A/ko not_active Withdrawn
- 2009-03-17 CN CN2009801096780A patent/CN101977624A/zh active Pending
- 2009-03-17 CA CA2717459A patent/CA2717459A1/en not_active Abandoned
- 2009-03-17 AU AU2009226966A patent/AU2009226966A1/en not_active Abandoned
- 2009-03-17 JP JP2011500199A patent/JP2011515363A/ja active Pending
- 2009-03-19 US US12/407,404 patent/US20100075893A1/en not_active Abandoned
- 2009-03-19 CL CL2009000675A patent/CL2009000675A1/es unknown
- 2009-03-19 TW TW098108936A patent/TW201000117A/zh unknown
- 2009-03-20 AR ARP090101004A patent/AR071010A1/es unknown
- 2009-03-20 PE PE2009000423A patent/PE20091690A1/es not_active Application Discontinuation
-
2010
- 2010-08-11 IL IL207542A patent/IL207542A0/en unknown
- 2010-08-23 ZA ZA2010/06004A patent/ZA201006004B/en unknown
- 2010-09-28 CO CO10119558A patent/CO6290697A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN101977624A (zh) | 2011-02-16 |
| PE20091690A1 (es) | 2009-11-13 |
| RU2010142903A (ru) | 2012-04-27 |
| KR20100135751A (ko) | 2010-12-27 |
| CO6290697A2 (es) | 2011-06-20 |
| TW201000117A (en) | 2010-01-01 |
| EP2265280A2 (en) | 2010-12-29 |
| US20100075893A1 (en) | 2010-03-25 |
| CA2717459A1 (en) | 2009-09-24 |
| IL207542A0 (en) | 2010-12-30 |
| AR071010A1 (es) | 2010-05-19 |
| AU2009226966A1 (en) | 2009-09-24 |
| JP2011515363A (ja) | 2011-05-19 |
| WO2009115525A3 (en) | 2010-03-18 |
| ZA201006004B (en) | 2011-05-25 |
| BRPI0908423A2 (pt) | 2015-08-04 |
| CL2009000675A1 (es) | 2009-08-07 |
| WO2009115525A2 (en) | 2009-09-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12021550756A1 (en) | Compositions and methods for treating and/or preventing cardiovascular disease | |
| IL261338B (en) | Preparations and methods for the treatment of wide-ranging, undifferentiated or mixed clinical applications | |
| MX2012000396A (es) | Metodos y composiciones para uso en tartamientos celulares. | |
| MX2010008696A (es) | Composiciones de proteina estabilizadas. | |
| MX2013002048A (es) | Conjugados, particulas, composiciones y metodos relacionados. | |
| IN2012DN00570A (es) | ||
| SG10201408158SA (en) | Composition and methods used during anti-hiv treatment | |
| EP2464626A4 (en) | PROCESSES, COMPOUNDS AND COMPOSITIONS FOR THE EXPORTS OF 1,3-PROPANE-SULFONIC ACID | |
| MX375079B (es) | ANTICUERPO NEUTRALIZANTE DE LA INTEGRINA AVß8. | |
| EP2432462A4 (en) | OXYGEN PROCEDURE AND COMPOSITIONS FOR THE TREATMENT OF MAMMALIAN DISEASES | |
| IL219876A (en) | Antibodies against human 1h-7b or its fragment, preparations containing them and their use in the preparation of drugs | |
| PL2424374T4 (pl) | Kompozycje środka oczyszczającego i metody jego stosowania | |
| MX2011009539A (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso. | |
| WO2011142858A3 (en) | Chlorotoxin variants, conjugates, and methods for their use | |
| EP2299828A4 (en) | COMPOSITIONS FOR LOW USE AGRICULTURE AND METHODS OF USE | |
| IL218490A (en) | Oxazolopyrimidinones dihydro hydroxybencyalkyloxymethyl are converted, preparations containing them and their use in the preparation of pharmaceutical preparations | |
| ZA200901132B (en) | Human GLP-1 mimetibodies, compositions, methods and uses | |
| IL207546A (en) | Medical compounds for use in the treatment or prevention of bone and joint disease | |
| EP2269653A4 (en) | COMPOSITION FOR THE STABILIZATION OF BLOCKER AND THE COMPOSITION COMPRISING TRANSDERMAL ABSORBABLE PREPARATION | |
| PL2252671T3 (pl) | Podobna do azeotropu kompozycja 1,1,1-trifluoro-3-chloropropenu i dimetoksymetanu | |
| EP2342559A4 (en) | METHODS AND COMPOSITIONS FOR PREVENTING ARTIFACTS IN TISSUE SAMPLES | |
| WO2010124085A3 (en) | Compositions and methods for preventing and treating uterine disease | |
| EP2502989A4 (en) | IMPLANT COMPOSITION FOR THE REGENERATION OF NEURAL TISSUE, PREPARATION METHOD AND USES THEREOF | |
| MX2010010016A (es) | Preparacion de composicion farmaceutica para aumentar densidad mineral osea. | |
| ZA201008384B (en) | Lasalocid compositions and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |